Wednesday, August 6, 2025
Washington DC, USA, August 7, 2025 – Barbados is advancing its industrial policy to boost local production of medicines and health technologies by enhancing its national regulatory framework. The country, supported by the Pan American Health Organization (PAHO/WHO), is conducting an assisted self-benchmarking exercise using the World Health Organization’s (WHO) Global Benchmarking Tool (GBT), alongside a clinical trials training webinar. A PAHO Medicines and Health Technologies (IMT) team collaborates with Barbados to align regulatory practices with international standards, including reviewing functions like marketing authorization and pharmacovigilance. The GBT identifies strengths and areas for improvement in regulatory functions, supporting the development of institutional roadmaps for strengthening regulatory systems. During the mission, PAHO works with Barbados’ regulators and stakeholders to address clinical trial oversight, emphasizing the roles of ethics committees. A high-level meeting led by Minister Dr. The Most Honourable Jerome Walcott discussed next steps to implement the national roadmap and expand access to health technologies. Barbados continues to lead in the Caribbean, prioritizing regulatory excellence and equitable health product access. PAHO remains a key partner, providing long-term support to the Government of Barbados in building resilient health systems. This initiative is part of PAHO’s broader effort to strengthen national regulatory systems, supporting public health priorities in the Region of the Americas. Strong regulatory systems ensure product safety, support local production, and enhance preparedness for health emergencies.
Reference: Barbados Advances Regulatory System with PAHO Support to Boost Local Health Production CapacityLabels: PAHO
0 Comments